Last reviewed · How we verify
zanamivir aqueous solution
At a glance
| Generic name | zanamivir aqueous solution |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza (PHASE3)
- A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection (PHASE3)
- Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults (PHASE1)
- Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital (PHASE2)
- Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |